Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

94.1%

+7.6% vs benchmark

Late-Stage Pipeline

14%

3 trials in Phase 3/4

Results Transparency

38%

6 of 16 completed with results

Key Signals

6 with results94% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (11)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 4 (3)

Trial Status

Completed16
Recruiting3
Enrolling By Invitation2
Terminated1

Trial Success Rate

94.1%

Benchmark: 86.6%

Based on 16 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06791044Not ApplicableRecruitingPrimary

25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases

NCT07681115RecruitingPrimary

An Investigation of the Effect of Vitamin D Level During Frozen Embryo Transfer (FET) in IVF and Pregnancy Outcomes

NCT07631312Not ApplicableCompleted

Collegiate Athlete Study

NCT07565064Enrolling By Invitation

ALPCO 25(OH) Vitamin D CLIA Kit - Fresh Versus Frozen Serum and Plasma Stability Study

NCT03621553Phase 4Recruiting

Vitamin D Homeostasis in Sarcoidosis

NCT07142759Not ApplicableEnrolling By InvitationPrimary

Investigating the Impact of Vitamin D Biofortified Tomatoes on Serum Levels of 25(OH)D

NCT04780776Not ApplicableCompleted

Evaluating the Effect of SOLIUS UV Light Source in Improving Vitamin D Status

NCT04735926Phase 2Completed

Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency

NCT04865432Not ApplicableCompleted

Solius UV Light Source in Improving Serum Levels of 25-hydroxyvitamin D

NCT03588884Phase 4Completed

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

NCT03660800Phase 1CompletedPrimary

Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

NCT02856776Not ApplicableCompletedPrimary

Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages

NCT02212652Not ApplicableTerminated

Vitamin D to Improve Nutrition Prior to Bariatric Surgery and Investigate the Relationship With Negative Outcomes

NCT01179503Early Phase 1Completed

Vitamin D Supplementation and Physical Function in Older Adults

NCT01349127Not ApplicableCompleted

Trial to Assess Vitamin D Requirements in Lactating Women

NCT02187146Completed

The Effects of Serum Vitamin D and IVF Outcome

NCT01219855Phase 2Completed

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

NCT01596842Phase 4Completed

Effect of Omega-3 Fatty Acid on Vitamin D Activation

NCT01375660Not ApplicableCompleted

D Vitamin Intervention in VA

NCT00273611Not ApplicableCompletedPrimary

Vitamin D Levels and Vitamin D Education in Geriatric Patients

Scroll to load more

Research Network

Activity Timeline